7-116910274-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate

The NM_006136.3(CAPZA2):​c.548C>T​(p.Pro183Leu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P183H) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)

Consequence

CAPZA2
NM_006136.3 missense

Scores

1
7
10

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 3.80

Publications

0 publications found
Variant links:
Genes affected
CAPZA2 (HGNC:1490): (capping actin protein of muscle Z-line subunit alpha 2) The protein encoded by this gene is a member of the F-actin capping protein alpha subunit family. It is the alpha subunit of the barbed-end actin binding protein Cap Z. By capping the barbed end of actin filaments, Cap Z regulates the growth of the actin filaments at the barbed end. [provided by RefSeq, Jul 2008]
CAPZA2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 1 curated pathogenic missense variants (we use a threshold of 10). The gene has 0 curated benign missense variants. Gene score misZ: 1.8416 (below the threshold of 3.09). Trascript score misZ: 1.2445 (below the threshold of 3.09). GenCC associations: The gene is linked to complex neurodevelopmental disorder.
BP4
Computational evidence support a benign effect (MetaRNN=0.25554633).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006136.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CAPZA2
NM_006136.3
MANE Select
c.548C>Tp.Pro183Leu
missense
Exon 7 of 10NP_006127.1A4D0V4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CAPZA2
ENST00000361183.8
TSL:1 MANE Select
c.548C>Tp.Pro183Leu
missense
Exon 7 of 10ENSP00000354947.2P47755-1
CAPZA2
ENST00000943391.1
c.572C>Tp.Pro191Leu
missense
Exon 7 of 10ENSP00000613450.1
CAPZA2
ENST00000903572.1
c.530C>Tp.Pro177Leu
missense
Exon 7 of 10ENSP00000573631.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
26
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
0.0023
T
BayesDel_noAF
Benign
-0.23
CADD
Uncertain
25
DANN
Benign
0.97
DEOGEN2
Benign
0.23
T
Eigen
Uncertain
0.25
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.86
D
M_CAP
Benign
0.0096
T
MetaRNN
Benign
0.26
T
MetaSVM
Benign
-0.41
T
MutationAssessor
Uncertain
2.4
M
PhyloP100
3.8
PrimateAI
Uncertain
0.71
T
PROVEAN
Pathogenic
-5.0
D
REVEL
Benign
0.24
Sift
Benign
0.078
T
Sift4G
Uncertain
0.027
D
Polyphen
0.033
B
Vest4
0.42
MutPred
0.55
Loss of catalytic residue at P183 (P = 0.0303)
MVP
0.23
MPC
0.74
ClinPred
0.98
D
GERP RS
5.5
Varity_R
0.29
gMVP
0.53
Mutation Taster
=67/33
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs933377766; hg19: chr7-116550328; COSMIC: COSV100753817; COSMIC: COSV100753817; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.